NCT00191425View on ClinicalTrials.gov

2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

PHASE4CompletedINTERVENTIONAL

Enrollment

810

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

November 30, 2005

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

Teriparatide

DRUG

Raloxifene

Trial Locations (1)

D-31812

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bad Pyrmont

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00191425 - 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis | Biotech Hunter | Biotech Hunter